Brief: AnaptysBio Q2 Net Income USD -46.66 Million
05/08/2024 21:15
Aug 05 (Reuters) - AnaptysBio Q2 collaboration revenue USD 10.971 million. * Q2 operating expenses USD 51.292 million * Q2 income from operations USD -40.321 million
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties